261 related articles for article (PubMed ID: 31655801)
1. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
Chernin G; Chen S; Ozan O; Liu M; Haberman D; Perlman G; Ben-Yehuda O; Jonas M
Am J Nephrol; 2019; 50(6):465-472. PubMed ID: 31655801
[TBL] [Abstract][Full Text] [Related]
2. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.
Baber U; Giustino G; Sartori S; Aquino M; Stefanini GG; Steg PG; Windecker S; Leon MB; Wijns W; Serruys PW; Valgimigli M; Stone GW; Dangas GD; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Mastoris I; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
JACC Cardiovasc Interv; 2016 Jan; 9(1):28-38. PubMed ID: 26762908
[TBL] [Abstract][Full Text] [Related]
3. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
[TBL] [Abstract][Full Text] [Related]
4. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
[TBL] [Abstract][Full Text] [Related]
5. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.
Siddiqi OK; Smoot KJ; Dufour AB; Cho K; Young M; Gagnon DR; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
Heart; 2015 Oct; 101(19):1569-76. PubMed ID: 26209334
[TBL] [Abstract][Full Text] [Related]
6. Everolimus Eluting Stents in Patients with Diabetes Mellitus and Chronic Kidney Disease: Insights from the TUXEDO Trial.
Bangalore S; Abhaichand R; Mullasari A; Jain R; Chand RKP; Arambam P; Kaul U
Cardiovasc Revasc Med; 2019 Dec; 20(12):1075-1080. PubMed ID: 31036397
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis.
Jonas M; Kagan M; Sella G; Haberman D; Chernin G
BMC Nephrol; 2020 Oct; 21(1):445. PubMed ID: 33097001
[TBL] [Abstract][Full Text] [Related]
8. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
[TBL] [Abstract][Full Text] [Related]
9. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
[TBL] [Abstract][Full Text] [Related]
10. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
[TBL] [Abstract][Full Text] [Related]
12. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
[TBL] [Abstract][Full Text] [Related]
13. Better Prognosis After Complete Revascularization Using Contemporary Coronary Stents in Patients With Chronic Kidney Disease.
Hwang D; Kang J; Yang HM; Yang S; Park J; Han JK; Kang HJ; Koo BK; Kim HS
Circ Cardiovasc Interv; 2019 Aug; 12(8):e007907. PubMed ID: 31345065
[TBL] [Abstract][Full Text] [Related]
14. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
Crimi G; Leonardi S; Costa F; Adamo M; Ariotti S; Valgimigli M
Int J Cardiol; 2016 Jun; 212():110-7. PubMed ID: 27038714
[TBL] [Abstract][Full Text] [Related]
15. Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.
Konigstein M; Ben-Yehuda O; Smits PC; Love MP; Banai S; Perlman GY; Golomb M; Ozan MO; Liu M; Leon MB; Stone GW; Kandzari DE
JACC Cardiovasc Interv; 2018 Dec; 11(24):2467-2476. PubMed ID: 30573057
[TBL] [Abstract][Full Text] [Related]
16. Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.
Kim J; Lee JM; Choi KH; Rhee TM; Hwang D; Park J; Ahn C; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Choi SH; Gwon HC
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29449272
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
18. The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.
Appleby CE; Ivanov J; Lavi S; Mackie K; Horlick EM; Ing D; Overgaard CB; Seidelin PH; von Harsdorf R; Dzavík V
Circ Cardiovasc Interv; 2009 Aug; 2(4):309-16. PubMed ID: 20031733
[TBL] [Abstract][Full Text] [Related]
19. Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Giustino G; Mastoris I; Baber U; Sartori S; Stone GW; Leon MB; Serruys PW; Kastrati A; Windecker S; Valgimigli M; Dangas GD; Von Birgelen C; Smits PC; Kandzari D; Galatius S; Wijns W; Steg PG; Stefanini GG; Aquino M; Morice MC; Camenzind E; Weisz G; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Chieffo A; Mehran R
JACC Cardiovasc Interv; 2016 Sep; 9(18):1890-901. PubMed ID: 27659564
[TBL] [Abstract][Full Text] [Related]
20. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.
Resmini C; Di Cuia M; Ballocca F; D'Ascenzo F; Bollati M; Moretti C; Omedè PL; Sciuto F; Gaita F; Sheiban I
Minerva Cardioangiol; 2012 Dec; 60(6):573-80. PubMed ID: 23147435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]